Sign in

International Parkinson and Movement Disorder Society®

@movedisorder.bsky.social
238 followers 100 following 516 posts
PostsRepliesMedia
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 3h
“ I have been involved in over 1,000 DBS cases — but I had never seen anything like this before.” Dr. Genko Oyama gives us an inside look at the last full day of the #mdscongress — including 2 exciting scientific breakthroughs and his favorite case from the Video Challenge: loom.ly/oSStfgM
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 4h
Congratulations to the winners of this year's #MDSCongress Video Challenge! Their interesting case was a unique challenge for the international experts. Gold: Malaysia, Joshua Ooi Silver: India, Arnab Adhya Bronze: Netherlands, Jeroen Kerstens
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 5h
Congratulations to the winners of this year's #MDSCongress Video Challenge! Their interesting case was a unique challenge for the international experts. Gold - Malaysia, Joshua Ooi Silver - India, Arnab Adhya Bronze - Netherlands, Jeroen Kerstens
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 07/10/2026
New #MDSCongress podcast: Join us for key takeaways from yesterday's sessions. loom.ly/e1zvYMk
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 07/10/2026
Tohru Minamino presents about "Immuno-gerotherapeutics Targeting Senescent Cells for Age-associated Diseases" during his keynote at the #MDSCongress.
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 07/10/2026
Thank you to the world-renown faculty who have shared their expertise at the 2026 #MDSCongress!
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 06/10/2026
“That was an eye-opener for me." —Dr. Sanjay Pandey New #MDSCongress podcast: Discover the surprising takeaways from yesterday's presidential lectures and sessions. loom.ly/jmB4A2o
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 05/10/2026
Tonight is #MDSCongress Networking Night! MDS young delegates, heath professionals, women in movement disorders, and basic scientists all had the opportunity to network and socialize with colleagues from across the globe.
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 05/10/2026
New #MDSCongress podcast: Scientific highlights from the event so far. loom.ly/F4N8__4
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 05/10/2026
Congratulations to Beomseok Jeon on receiving the Stanley Fahn Lecture Award at the #MDSCongress. He discussed "GCH-1 and Parkinson disease."
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 05/10/2026
Congratulations to Vincenzo Bonifati on receiving the C. David Marsden Lecture Award at the #MDSCongress. He shared about "Paths to discovery and understanding: pedigrees, genes and movement disorders."
010
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 05/10/2026
Congratulations to Junior Awardees Zixiao Yin and Richard Morton for their contributions to basic science and clinical research in the field of Movement Disorders. #MDSCongress
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 04/10/2026
Kibra Kebede is recognized with the Public Service Award. Kibra is a disability rights advocate and founder of Ethiopia’s first Parkinson’s support organization, bringing clinical care, dignity, and economic stability to people with disabilities in underserved communities. #MDSCongress
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 04/10/2026
Congratulations to Timothy Lynch and Irena Rektorova for receiving the President’s Distinguished Service Award at the #MDSCongress; this award is bestowed directly by the MDS President in recognition of their long and distinguished service to the Society and the field.
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 04/10/2026
Congratulations to the newest MDS Honorary Members — individuals who have made extraordinary contributions to the Society: Michael Okun and A. Jon Stoessl! #MDSCongress
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 04/10/2026
Congratulations to the 2026 MDS Presidential Honorary Member, Victor Fung!
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 04/10/2026
Welcome from 2026 #MDSCongress in Seoul, Korea! This year, we are exploring "Understanding Aging in Movement Disorders."
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 04/10/2026
Explore all 2,000+ novel research findings at #MDSCongress at mdsabstracts.org.
001
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 03/10/2026
A person’s symptoms for multiple system atrophy (MSA) typically appear in a person’s 50s and can be categorized as Parkinsonian type or cerebellar type MSA.  
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 03/10/2026
MDS wishes to acknowledge the following Bronze Level supporters of the 2026 International Congress: Sumitomo Pharma Co., Ltd. (MARQUEE SPONSOR), uMed, uniQure, and Vima Therapeutics.
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 03/10/2026
MDS wishes to acknowledge the following Bronze Level supporters of the 2026 International Congress: neuroClues, Neuron23, Novartis Pharma AG, Parexel International, LLC, Rishena Medical Co., Ltd, Roche (MARQUEE SPONSOR), SAMSUNG PHARM. Co., LTD., and SK Biopharmaceuticals.
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 03/10/2026
MDS wishes to acknowledge the following Bronze Level supporters of the 2026 International Congress: Celestra Health Systems, Dasher Neuroscience Inc., Eisai Korea Inc., Empatica, Ferrer, FHC, Inc., Fulgent Genetics, GemVax&KAEL Co., Ltd., Indivi, IntraBio, Ipsen, JSC Vilimed, and NeuraLight.
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 03/10/2026
MDS wishes to acknowledge the following Bronze Level supporters of the 2026 International Congress: Abbott, ActualSignal, Advanced Brain Monitoring, Inc., Amprion Inc., Arvinas Operations, Inc., Association of Movement Disorder Advanced Practice Providers, and AT&C Co., Ltd. #MDSCongress
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 03/10/2026
MDS wishes to acknowledge the following Silver Level supporters of the 2026 International Congress: Abbott (MARQUEE SPONSOR), Teva Pharmaceuticals, Insightec (MARQUEE SPONSOR), Regeneron, STADA Specialty, Korea Tourism Organization, and Seoul Metropolitan Government. #MDSCongress
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 03/10/2026
MDS wishes to acknowledge the following Gold Level supporters of the 2026 International Congress: Amneal Pharmaceuticals (MARQUEE SPONSOR), Boston Scientific, and Medtronic. #MDSCongress
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 03/10/2026
MDS wishes to acknowledge the following Platinum Level supporters of the 2026 International Congress: AbbVie, H. Lundbeck A/S, Praxis Precision Medicines, and Supernus Pharmaceuticals. #MDSCongress
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 03/10/2026
MDS wishes to acknowledge the following Diamond Level supporter of the 2026 International Congress: Bayer / AskBio Inc. / BlueRock Therapeutics. #MDSCongress
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 01/10/2026
Pairs of clinical residents and basic science trainees can apply for funding and mentorship for a collaborative translational project. Apply today: loom.ly/gYjnK-g
movementdisorders.org
MDS-ES Grow Together in Clinical-Science Pilot Program
Step into the other side of translational medicine by working on a collaborative project.
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 30/09/2026
Prof. Vincenzo Bonifati, winner of this year's C. David Marsden Presidential Lecture Award, discusses his landmark genetic discoveries as well as what the near future holds for movement disorder research. loom.ly/EWcVZaU
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 30/09/2026
MDS Young Member Group Research Highlight: Researchers associate monoamine neurotransmitter abnormalities with depression, anxiety, and REM sleep behavior disorder, though not with cognition. loom.ly/UKqUK5E
movementdisorders.org
Monoaminergic networks of cognitive and behavioral symptoms in early Parkinson's disease
Researchers associate monoamine neurotransmitter abnormalities with depression, anxiety, and REM sleep behavior disorder, though not with cognition.
001
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 29/09/2026
Given the same body of evidence, how can conclusions in evidence-based reviews differ from evidence-based clinical practice guidelines? The answer lies in each work's stated objectives, NOT a lack of scientific objectivity. #EBM loom.ly/80LkWSc
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 29/09/2026
Implanted stem cells for symptomatic treatment? Emerging Alzheimer's disease therapies repurposed for Parkinson's? Attend this plenary session to hear experts debate the cases for and against these innovative yet still developing interventions. #MDSCongress Mdscongress.org
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 28/09/2026
What can prevalence data tell us about Parkinson’s disease in Kenya? MDS Congress 2026 Junior Award Winner Dr. Richard Morton discusses his study in Kilifi County, part of the Transforming Parkinson’s Care in Africa (TraPCAf) study, with Dr. Sara Schaefer. loom.ly/uTZ4epE
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 28/09/2026
RLS is epidemiologically heterogeneous and has diagnostic overlaps with other similar conditions. This module breaks down the pathophysiology, diagnostic criteria, and treatment options of RLS. loom.ly/GWacHCk
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 28/09/2026
New at the #MDSCongress Pediatric Workshop: Discover the latest advancements in one of the fastest-evolving areas in the field. Explore cutting-edge clinical approaches, translational science, and emerging disease-modifying strategies. loom.ly/ZTINbwA
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 25/09/2026
Progressive ataxia has many possible causes. When chorea is present alongside ataxia, it provides an important clinical clue that can narrow the diagnosis and help guide a more focused evaluation of degenerative, inherited, or acquired disorders. 
010
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 25/09/2026
DBS treatment sends electrical signaling to the brain, but these systems also listen as the brain signals back! Find out what Junior Awardee Dr. Zixiao Yin learned when his research team put adaptive DBS's ability to respond to cortical signals to the test. #MDSCongress mdscongress.org
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 24/09/2026
Discover the clinical features specific to PD patients with a GCH-1 mutation and how presence of this genetic variant may affect your approach to levodopa dosing. Don't miss outstanding scholar Dr. Beomseok Jeon present the 2026 Stanley Fahn Lecture. #MDSCongress mdscongress.org
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 24/09/2026
What sessions are you most excited for? #MDSCongress loom.ly/WyQTzYA
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 23/09/2026
Step into the other side of translational medicine by working on a collaborative project. Apply as a pair today: loom.ly/gYjnK-g
movementdisorders.org
MDS-ES Grow Together in Clinical-Science Pilot Program
Step into the other side of translational medicine by working on a collaborative project.
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 23/09/2026
One of this year's Junior Awardees, Dr. Zixiao Yin, shares his work on decoding deep brain activity using cortical signals. Listen as he explains the deep learning technology and what this can do for the future of adaptive DBS and clinical care. loom.ly/3Kbmj-Y
020
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 23/09/2026
About 5%-10% of the general population has RLS, making it one of the most common movement disorders. Here are 5 things to know about RLS. 
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 23/09/2026
A simple but powerful question: Can we reduce the chances that Parkinson’s disease develops in the first place? loom.ly/OuRsst0
movementdisorders.org
It's time to talk primary prevention for Parkinson's disease: The 8 C's
A simple but powerful question: Can we reduce the chances that Parkinson’s disease develops in the first place?
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 22/09/2026
Join top AOS clinicians to analyze contemporary trends in the field, using real-world cases. loom.ly/OdjexDA
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 22/09/2026
FDA approval of bilateral pallidothalamic tractotomy using focused ultrasound creates an imperative to refine evidence-based patient selection criteria for two-sided brain ablation. loom.ly/mkQs49s
movementdisorders.org
An old question, a new technology: Bilateral ablation in Parkinson’s disease
FDA approval of bilateral pallidothalamic tractotomy using focused ultrasound creates an imperative to refine evidence-based patient selection criteria for two-sided brain ablation
010
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 21/09/2026
2026 Stanley Fahn Award Lecture winner Dr. Beomseok Jeon reflects on his career and the influence of Dr. Stanley Fahn, including the inspiration he drew from his time as a movement disorders fellow. Listen as he discusses his journey with Dr. Sara Schaefer. loom.ly/jqAi8ic
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 21/09/2026
While representation of women authors in the field of movement disorder publishing increased since 2014, there remains a persistent gender gap in senior authorship, per a bibliometric analysis by the Women in MD Special Interest Group Steering Committee. loom.ly/jogpHiw
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 21/09/2026
Are you missing critical perspectives in patient care? Gain insights to coordinate and work more effectively across the care team. loom.ly/U7qHSzs
000
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 18/09/2026
Deep brain stimulation for severe dystonia can result in remarkable improvement of a child’s physical function. Take this MDS Fundamentals course to watch pre/post-treatment patient videos and to learn more about this off-label application of DBS. loom.ly/axmgg-4
001
International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 17/09/2026
Panel brings together epidemiologists, toxicologists, geneticists and neurologists to decipher the ways environmental factors and genetic predisposition contribute to PD risk and progression. loom.ly/jHVoaj4
movementdisorders.org
MDS convenes Task Force on Parkinson’s Disease Exposome Integration
Panel brings together epidemiologists, toxicologists, geneticists and neurologists to decipher the ways environmental factors and genetic predisposition contribute to PD risk and progression.
000